PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+6.17%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$918M
AUM Growth
+$918M
(-8%)
Cap. Flow
-$47.2M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
48.67%
Holding
156
New
37
Increased
25
Reduced
25
Closed
31
Top Buys
| 1 |
AFMD
Affimed
AFMD
|
$63M |
| 2 |
OTIC
Otonomy, Inc.
OTIC
|
$20.1M |
| 3 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$12.2M |
| 4 |
Arrowhead Research
ARWR
|
$12.2M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$11M |
Top Sells
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$37M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$25.8M |
| 3 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$24.7M |
| 4 |
SHPG
Shire pic
SHPG
|
$21.2M |
| 5 |
Insmed
INSM
|
$15.7M |
Sector Composition
| 1 | Healthcare | 88.14% |
| 2 | Financials | 0.2% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $73.4M | 7.43% | 12,339,444 | – | – |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $71.5M | 7.24% | 4,565,267 -34,600 | -0.8% | -$542K |
|
|
AFMD
3
DELISTED
Affimed
AFMD
| $63M | 6.38% | +999,989 | New | +$63M |
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $54.8M | 5.55% | 2,596,691 +38,213 | +1% | +$806K |
|
5
Talphera
TLPH
$11.1M
| $36.1M | 3.65% | 6,574,060 | – | – |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $35.8M | 3.62% | 377,448 -130,040 | -26% | -$12.3M |
|
7
PTC Therapeutics
PTCT
$3.92B
| $29.6M | 2.99% | 671,736 | – | – |
|
|
DYAX
8
DELISTED
DYAX CORPORATION
DYAX
| $28.7M | 2.9% | 2,835,498 +124,900 | +5% | +$1.26M |
|
|
9
Acadia Pharmaceuticals
ACAD
$4.38B
| $27.2M | 2.75% | 1,097,914 +444,914 | +68% | +$11M |
|
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $27M | 2.73% | 240,142 -230,000 | -49% | -$25.8M |
|
11
Zimmer Biomet
ZBH
$21B
| $25.4M | 2.57% | 252,500 +10,000 | +4% | +$1.01M |
|
|
TARO
12
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $21.7M | 2.19% | 140,935 -160,398 | -53% | -$24.7M |
|
13
Iovance Biotherapeutics
IOVA
$807M
| $20.8M | 2.11% | 2,914,549 -97,000 | -3% | -$694K |
|
|
ISEE
14
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $20.3M | 2.05% | 520,165 +148,696 | +40% | +$5.79M |
|
|
OTIC
15
DELISTED
Otonomy, Inc.
OTIC
| $20.1M | 2.03% | +837,400 | New | +$20.1M |
|
|
RCPT
16
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $19.5M | 1.97% | 313,594 +108,594 | +53% | +$6.74M |
|
|
TSRO
17
DELISTED
TESARO, Inc.
TSRO
| $19.1M | 1.93% | 708,284 +71,328 | +11% | +$1.92M |
|
|
18
Arrowhead Research
ARWR
$3.05B
| $18.4M | 1.87% | 1,247,495 +825,089 | +195% | +$12.2M |
|
19
Xencor
XNCR
$580M
| $17.9M | 1.81% | 1,922,707 +182,086 | +10% | +$1.7M |
|
20
HCA Healthcare
HCA
$94.5B
| $16.2M | 1.64% | 230,306 +32,500 | +16% | +$2.29M |
|
|
RLYP
21
DELISTED
RELYPSA INC COM
RLYP
| $16.1M | 1.63% | 762,705 +166,100 | +28% | +$3.5M |
|
|
XLRN
22
DELISTED
Acceleron Pharma Inc.
XLRN
| $13.5M | 1.36% | 445,000 +145,000 | +48% | +$4.38M |
|
23
Travere Therapeutics
TVTX
$1.56B
| $12.4M | 1.26% | 1,379,137 +104,845 | +8% | +$946K |
|
|
AEGR
24
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $12.2M | 1.24% | +366,754 | New | +$12.2M |
|
|
ARAV
25
DELISTED
Aravive, Inc. Common Stock
ARAV
| $9.25M | 0.94% | 487,262 +171,466 | +54% | +$3.26M |
|